Alpha Tau Medical Statistics
Total Valuation
DRTS has a market cap or net worth of $187.88 million. The enterprise value is $135.22 million.
Important Dates
The next estimated earnings date is Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DRTS has 70.10 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 70.10M |
| Shares Outstanding | 70.10M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 21.89% |
| Owned by Institutions (%) | 5.33% |
| Float | 54.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.69 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.99, with a Debt / Equity ratio of 0.18.
| Current Ratio | 10.99 |
| Quick Ratio | 10.27 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -476.15 |
Financial Efficiency
Return on equity (ROE) is -37.22% and return on invested capital (ROIC) is -25.10%.
| Return on Equity (ROE) | -37.22% |
| Return on Assets (ROA) | -22.61% |
| Return on Invested Capital (ROIC) | -25.10% |
| Return on Capital Employed (ROCE) | -42.32% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$244,950 |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DRTS has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.55% in the last 52 weeks. The beta is 0.84, so DRTS's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -13.55% |
| 50-Day Moving Average | 3.35 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 28.55 |
| Average Volume (20 Days) | 108,644 |
Short Selling Information
The latest short interest is 101,855, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 101,855 |
| Short Previous Month | 129,982 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.19% |
| Short Ratio (days to cover) | 0.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -35.71M |
| Pretax Income | -29.14M |
| Net Income | -29.64M |
| EBITDA | -34.57M |
| EBIT | -35.71M |
| Earnings Per Share (EPS) | -$0.42 |
Full Income StatementBalance Sheet
The company has $65.22 million in cash and $12.57 million in debt, giving a net cash position of $52.66 million or $0.75 per share.
| Cash & Cash Equivalents | 65.22M |
| Total Debt | 12.57M |
| Net Cash | 52.66M |
| Net Cash Per Share | $0.75 |
| Equity (Book Value) | 69.40M |
| Book Value Per Share | 1.00 |
| Working Capital | 63.44M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |